VOYA Investment Management’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Buy |
20,012
+242
| +1% | +$3.38K | ﹤0.01% | 2183 |
|
|
2025
Q1 | $267K | Sell |
19,770
-1,627
| -8% | -$21.9K | ﹤0.01% | 2176 |
|
|
2024
Q4 | $410K | Buy |
21,397
+1,038
| +5% | +$19.9K | ﹤0.01% | 2026 |
|
|
2024
Q3 | $463K | Sell |
20,359
-591
| -3% | -$13.4K | ﹤0.01% | 2035 |
|
|
2024
Q2 | $273K | Buy |
20,950
+5,965
| +40% | +$77.6K | ﹤0.01% | 2300 |
|
|
2024
Q1 | $262K | Sell |
14,985
-1,697
| -10% | -$29.7K | ﹤0.01% | 2321 |
|
|
2023
Q4 | $363K | Sell |
16,682
-370
| -2% | -$8.06K | ﹤0.01% | 2236 |
|
|
2023
Q3 | $262K | Buy |
17,052
+297
| +2% | +$4.56K | ﹤0.01% | 2381 |
|
|
2023
Q2 | $399K | Buy |
16,755
+2,458
| +17% | +$58.5K | ﹤0.01% | 2210 |
|
|
2023
Q1 | $364K | Hold |
14,297
| – | – | ﹤0.01% | 2222 |
|
|
2022
Q4 | $418K | Buy |
14,297
+3,877
| +37% | +$113K | ﹤0.01% | 2130 |
|
|
2022
Q3 | $214K | Buy |
+10,420
| New | +$214K | ﹤0.01% | 2567 |
|
|
2019
Q2 | – | Sell |
-10,551
| Closed | -$29K | – | 2617 |
|
|
2019
Q1 | $29K | Hold |
10,551
| – | – | ﹤0.01% | 2532 |
|
|
2018
Q4 | $32K | Hold |
10,551
| – | – | ﹤0.01% | 2522 |
|
|
2018
Q3 | $59K | Hold |
10,551
| – | – | ﹤0.01% | 2556 |
|
|
2018
Q2 | $68K | Buy |
+10,551
| New | +$68K | ﹤0.01% | 2578 |
|